SELLAS Life Sciences (SLS) Asset Utilization Ratio (2020 - 2022)

SELLAS Life Sciences (SLS) has disclosed Asset Utilization Ratio for 3 consecutive years, with 0.04 as the latest value for Q4 2022.

  • On a quarterly basis, Asset Utilization Ratio fell 82.0% to 0.04 in Q4 2022 year-over-year; TTM through Dec 2022 was 0.04, a 82.0% decrease, with the full-year FY2022 number at 0.04, down 79.85% from a year prior.
  • Asset Utilization Ratio was 0.04 for Q4 2022 at SELLAS Life Sciences, down from 0.12 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.24 in Q4 2021 to a low of 0.04 in Q4 2022.
  • A 3-year average of 0.16 and a median of 0.18 in 2021 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: skyrocketed 302.06% in 2021, then crashed 82.0% in 2022.
  • SELLAS Life Sciences' Asset Utilization Ratio stood at 0.06 in 2020, then skyrocketed by 302.06% to 0.24 in 2021, then plummeted by 82.0% to 0.04 in 2022.
  • Per Business Quant, the three most recent readings for SLS's Asset Utilization Ratio are 0.04 (Q4 2022), 0.12 (Q1 2022), and 0.24 (Q4 2021).